Product news from the 12/05/06 news brief
Alimera Sciences, an ophthalmic pharmaceutical company founded just three years ago, said the FDA approved an Rx-to-OTC switch new drug ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.